Pharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection. - Canini L; Koh C; Cotler SJ; Uprichard SL; Winters MA; Han MAT; Kleiner DE; Idilman R; Yurdaydin C; Glenn JS; Heller T; Dahari H (Hepatology communications, 2017)